- NCIt
- C2960
Loading cancer entity…
Loading cancer entity…
Clinical trials
67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07698886 | Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel | recruiting | Phase 2 | 70 | KTH BiopharmaINDUSTRY | 1 | Sep 10, 2026 | clinicaltrials |
| NCT06756269 | To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years | recruiting | Phase 2 | 330 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05087849 | Intralesional HPV Vaccine for Condylomata | completed | Phase 1 / Phase 2 | 2 | University of California, San FranciscoOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT02462187 | Topical NVN1000 for the Treatment of External Genital and Perianal Warts |
Data updated 19 days agoSource updated Sep 10, 2026source: clinicaltrials
| completed |
| Phase 2 |
| 108 |
| Novan, Inc.INDUSTRY |
| 1 |
| Apr 6, 2023 |
| clinicaltrials |
| NCT01796821 | Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) | completed | Phase 2 | 138 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 1 | Feb 5, 2020 | clinicaltrials |
| NCT00520598 | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | completed | Phase 2 | 511 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 26, 2015 | clinicaltrials |
| NCT00551187 | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) | completed | Phase 2 | 620 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2015 | clinicaltrials |
| NCT01639638 | Recurrent and Nonrecurrent Condyloma Treatment | terminated | Phase 2 / Phase 3 | 132 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Mar 12, 2015 | clinicaltrials |
| NCT01555112 | Safety and Efficacy Study to Test Topical AS101 for External Genital Warts | completed | Phase 1 / Phase 2 | 12 | BioMAS LtdINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |